Early detection and differential serodiagnosis of Mycoplasma hyorhinis and Mycoplasma hyosynoviae infections under experimental conditions.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
05
2019
accepted:
20
09
2019
entrez:
8
10
2019
pubmed:
8
10
2019
medline:
11
3
2020
Statut:
epublish
Résumé
Mycoplasma hyorhinis (MHR) and Mycoplasma hyosynoviae (MHS) are common opportunistic pathogens in the upper respiratory tract and tonsils of swine. The identification of the specific species involved in clinical cases using conventional diagnostic methods is challenging. Therefore, a recombinant chimeric polypeptide based on the seven known variable lipoproteins (A-G) specific of MHR and a cocktail of surface proteins detergent-extracted from MHS cultures were generated and their suitability as antemortem biomarkers for serodiagnosis of MHR- and MHS-infection were evaluated by ELISA. M. hyorhinis and MHS ELISA performance, evaluated using serum samples collected over a 56-day observation period from pigs inoculated with MHR, MHS, M. hyopneumoniae, M. flocculare, or Friis medium, varied by assay, targeted antibody isotype, and cutoffs. The progressions of MHR and MHS clinical diseases were evaluated in relation to the kinetics of the isotype-specific antibody response in serum and bacterial shedding in oral fluids during the observation period. In pigs inoculated with MHR, bacterial DNA was detected in one or more of the 5 pens at all sampling points throughout the study, IgA was first detected at DPI 7, one week before the first clinical signs, with both IgA and IgG detected in all samples collected after DPI 14. The peak of MHS shedding (DPI 8) coincided with the onset of the clinical signs, with both IgA and IgG detected in all serum samples collected ≥ DPI 14. This study demonstrated, under experimental conditions, that both ELISAs were suitable for early detection of specific antibodies against MHR or MHS. The diagnostic performance of the MHR and MHS ELISAs varied depending on the selected cutoff and the antibody isotype evaluated. The high diagnostic and analytical specificity of the ELISAs was particularly remarkable. This study also provides insights into the infection dynamics of MHR-associated disease and MHS-associated arthritis not previously described.
Identifiants
pubmed: 31589633
doi: 10.1371/journal.pone.0223459
pii: PONE-D-19-13076
pmc: PMC6779295
doi:
Substances chimiques
Antibodies, Bacterial
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0223459Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Zentralbl Veterinarmed A. 1999 Nov;46(9):555-64
pubmed: 10605365
Isr J Med Sci. 1987 Jun;23(6):654-6
pubmed: 3667232
J Vet Res. 2017 Dec 6;61(2):163-171
pubmed: 29978069
Am J Vet Res. 1955 Oct;16(61 Part 1):540-4
pubmed: 13259032
Vet Microbiol. 2014 Nov 7;174(1-2):163-71
pubmed: 25240775
Acta Vet Scand. 1971;12(1):69-79
pubmed: 5575144
Can J Vet Res. 2012 Jul;76(3):195-200
pubmed: 23277698
Zentralbl Veterinarmed B. 1972 May;19(5):379-90
pubmed: 5051221
Vet Microbiol. 2006 Jun 15;115(1-3):111-6
pubmed: 16540266
J Bacteriol. 1970 Sep;103(3):707-13
pubmed: 4991614
Vet Microbiol. 2005 Nov 30;111(1-2):41-50
pubmed: 16171955
J Bacteriol. 2000 Mar;182(5):1356-63
pubmed: 10671459
APMIS. 1999 Feb;107(2):201-10
pubmed: 10225318
Am J Vet Res. 1963 May;24:622-7
pubmed: 13975123
J Bacteriol. 1995 Oct;177(19):5636-43
pubmed: 7559353
Rev Sci Tech. 1996 Dec;15(4):1569-605
pubmed: 9190026
Can J Comp Med. 1984 Apr;48(2):202-7
pubmed: 6372971
Zentralbl Veterinarmed B. 1969;16(3):253-65
pubmed: 5815858
Acta Vet Scand. 1991;32(4):425-9
pubmed: 1818502
Trop Anim Health Prod. 2012 Feb;44(2):313-8
pubmed: 22116666
J Vet Diagn Invest. 2014 Nov;26(6):755-60
pubmed: 25319032
J Bacteriol. 1994 Apr;176(8):2463-7
pubmed: 7512554
Emerg Infect Dis. 1997 Jan-Mar;3(1):21-32
pubmed: 9126441
Vet Microbiol. 1982 May;7(2):135-46
pubmed: 7112893
Am J Vet Res. 1977 Dec;38(12):2075-6
pubmed: 596706
J Clin Microbiol. 2008 Aug;46(8):2491-8
pubmed: 18524960
Am J Vet Res. 1994 Jan;55(1):81-4
pubmed: 8141501
J Vet Sci. 2015;16(2):195-201
pubmed: 25643803
Vet Rec. 2017 Jul 15;181(3):68
pubmed: 28424318
Am J Vet Res. 1973 Mar;34(3):367-72
pubmed: 4691485
EMBO J. 1991 Dec;10(13):4069-79
pubmed: 1721868
Vet Microbiol. 2018 Feb;214:13-20
pubmed: 29408024
Acta Vet Scand. 1974;15(4):507-18
pubmed: 4455082
Berl Munch Tierarztl Wochenschr. 1989 Jan 1;102(1):11-3
pubmed: 2647076
Am J Vet Res. 1971 Nov;32(11):1743-9
pubmed: 4941436
J S Afr Vet Assoc. 1982 Jun;53(2):99-101
pubmed: 6750122
Acta Vet Scand. 1994;35(1):93-8
pubmed: 8209825
J Clin Microbiol. 2000 Apr;38(4):1390-6
pubmed: 10747113
Science. 1990 Jan 19;247(4940):315-8
pubmed: 1688663
Vet Immunol Immunopathol. 1992 Feb 15;31(1-2):141-53
pubmed: 1570675
Vet Res Commun. 2006 Apr;30(3):239-47
pubmed: 16437299
Yale J Biol Med. 1976 May;49(2):175-95
pubmed: 782050
J Bacteriol. 1991 Aug;173(15):4782-93
pubmed: 1856172
Braz J Med Biol Res. 2006 Jul;39(7):907-14
pubmed: 16862282
J Vet Diagn Invest. 2008 Mar;20(2):156-63
pubmed: 18319427
J Vet Diagn Invest. 1992 Jan;4(1):28-30
pubmed: 1554766
Bacteriol Rev. 1965 Jun;29:185-221
pubmed: 14304038